MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Manipal Health Enterprises Ltd › Financials
MA
Manipal Health Enterprises Ltd
CLOSED NSE & BSE Bookbuilding IPO Fresh capital cum OFS Manipal Health Enterprises IPO GMP
GREY MARKET PREMIUM
₹ + 1
+0% expected return
EST. LISTING PRICE
₹591
Issue Price: ₹ 590
Issue Price
₹590
Face Value
₹2
Lot Size
25 shares
Open Date
29 Jul 2026
Close Date
31 Jul 2026
Allotment
03 Aug 2026
Listing Date
05 Aug 2026
Exchange
NSE & BSE

Manipal Health Enterprises IPO Details: Price, Dates & Financials

The Manipal Health Enterprises IPO is a closed mainboard Bookbuilding offer (Fresh capital cum OFS) that opened on 29 July 2026. The Manipal Health Enterprises IPO closed on 31 July 2026, with an issue price of ₹590 per share. The Manipal Health Enterprises IPO has a face value of ₹2 and a lot size of 25 shares. The Manipal Health Enterprises IPO is listed on 5 August 2026. The Manipal Health Enterprises IPO allotment was scheduled for 3 August 2026.

On the financial front, the Manipal Health Enterprises IPO reported revenue of ₹10,521 crore for 31 Mar 2026, compared with ₹8,363 crore for 31 Mar 2025. The Manipal Health Enterprises IPO PAT was ₹917 crore against ₹1,082 crore. The Manipal Health Enterprises IPO EBITDA stood at ₹2,796 crore with a 27.05% margin. The Manipal Health Enterprises IPO net worth as of 31 Mar 2026 was ₹8,441 crore.

Always verify The Manipal Health Enterprises IPO details and GMP data with the official offer document before investing in the Manipal Health Enterprises IPO.

Financial Summary Amount in ₹ Crore
Metric 31 Mar 2026 31 Mar 2025 31 Mar 2024
Total Assets 24,865 14,072 10,819
Revenue 10,521 8,363 6,265
PAT 917 1,082 533
EBITDA 2,796 2,247 1,777
Net Worth 8,441 5,866 4,029
Reserves 8,205 5,789 3,954
Total Borrowing 10,553 4,767 3,944
Manipal Health Enterprises IPO Financials FAQs
Revenue of Manipal Health Enterprises (Amount in ₹ Crore) — 31 Mar 2026: 10,521; 31 Mar 2025: 8,363; 31 Mar 2024: 6,265. Profit after tax (PAT) — 31 Mar 2026: 917; 31 Mar 2025: 1,082; 31 Mar 2024: 533.
EBITDA of Manipal Health Enterprises (Amount in ₹ Crore) — 31 Mar 2026: 2,796; 31 Mar 2025: 2,247; 31 Mar 2024: 1,777. The EBITDA margin is 27.05%.
Total assets — 31 Mar 2026: 24,865; 31 Mar 2025: 14,072; 31 Mar 2024: 10,819. Net worth — 31 Mar 2026: 8,441; 31 Mar 2025: 5,866; 31 Mar 2024: 4,029. Reserves & surplus — 31 Mar 2026: 8,205; 31 Mar 2025: 5,789; 31 Mar 2024: 3,954. (Amount in ₹ Crore)
Total borrowing of Manipal Health Enterprises (Amount in ₹ Crore) — 31 Mar 2026: 10,553; 31 Mar 2025: 4,767; 31 Mar 2024: 3,944.
The financials shown for Manipal Health Enterprises IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.